TY - JOUR
T1 - A Preliminary Protocol for Induction of Tuberculosis Spondylitis by Mycobacterium Tuberculosis Strain H37R
T2 - In-vivo New Zealand White Rrabbits Model
AU - Siregar, Otman
AU - Lelo, Aznan
AU - Rahyussalim,
AU - Ilyas, Syafruddin
AU - Benny,
AU - Kurniawati, Tri
AU - Augustinus, Yohanes
AU - Hendra,
AU - Mandagi, Tommy
AU - Zufar, Muhammad Luqman Labib
N1 - Publisher Copyright:
© 2022 by SPC (Sami Publishing Company)
PY - 2022/11/1
Y1 - 2022/11/1
N2 - Background: Proper animal model is a critical prerequisite of any experimental study, while it is a lack for tuberculosis spondylitis. This study aimed to validate a protocol for induction of tuberculosis spondylitis in an animal model. Methods: Ten New Zealand white rabbits were used and divided randomly into four experimental groups (n = 8), with 2 rabbits in each group, and the control group (n = 2). A 0.2 mL suspension of 108 CFU/mL H37Rv strain M. tuberculosis was delivered into the drilled hole with a depth of 6-10 mm at the midpoint of the 12th thoracal corpus compared with the saline in the control group. Evaluation of imaging examination by using plain X-ray was done within the targeted time followed by euthanasia protocol. Results: A survival rate of 100% was observed in the present study with all rabbits having stable vital signs during the incubation period. Group 3 with an incubation period of 6 weeks showed the highest success rate for inoculation of M. tuberculosis bacteria in which 7 samples were positive. This was followed by group 2 (75%, incubation 4 weeks), group 1 (37.5%, incubation 2 weeks), and group 4 (12.5%, incubation 8 weeks). The high positive rates were also reported by using culture and PCR staining, 62.5% and 75%, respectively. A slight destruction of the vertebral body was observed in both groups 2 and 3 starting at 4 weeks, postoperatively. Histopathology specimen exhibited an infiltration of numerous inflammatory cells. Conclusions: Establishment of spondylitis tuberculosis model by using New Zealand white rabbit could be successfully formed through 0.2 mL suspension of 108 CFU/mL M. tuberculosis strain H37Rv with a direct inoculation method towards the midpoint of the 12th thoracal vertebral body.
AB - Background: Proper animal model is a critical prerequisite of any experimental study, while it is a lack for tuberculosis spondylitis. This study aimed to validate a protocol for induction of tuberculosis spondylitis in an animal model. Methods: Ten New Zealand white rabbits were used and divided randomly into four experimental groups (n = 8), with 2 rabbits in each group, and the control group (n = 2). A 0.2 mL suspension of 108 CFU/mL H37Rv strain M. tuberculosis was delivered into the drilled hole with a depth of 6-10 mm at the midpoint of the 12th thoracal corpus compared with the saline in the control group. Evaluation of imaging examination by using plain X-ray was done within the targeted time followed by euthanasia protocol. Results: A survival rate of 100% was observed in the present study with all rabbits having stable vital signs during the incubation period. Group 3 with an incubation period of 6 weeks showed the highest success rate for inoculation of M. tuberculosis bacteria in which 7 samples were positive. This was followed by group 2 (75%, incubation 4 weeks), group 1 (37.5%, incubation 2 weeks), and group 4 (12.5%, incubation 8 weeks). The high positive rates were also reported by using culture and PCR staining, 62.5% and 75%, respectively. A slight destruction of the vertebral body was observed in both groups 2 and 3 starting at 4 weeks, postoperatively. Histopathology specimen exhibited an infiltration of numerous inflammatory cells. Conclusions: Establishment of spondylitis tuberculosis model by using New Zealand white rabbit could be successfully formed through 0.2 mL suspension of 108 CFU/mL M. tuberculosis strain H37Rv with a direct inoculation method towards the midpoint of the 12th thoracal vertebral body.
KW - Animal Model
KW - Mycobacterium tuberculosis
KW - New Zealand rabbit
KW - Spinal Tuberculosis
KW - Spondylitis Tuberculosis
UR - http://www.scopus.com/inward/record.url?scp=85138052505&partnerID=8YFLogxK
U2 - 10.26655/JMCHEMSCI.2022.7.19
DO - 10.26655/JMCHEMSCI.2022.7.19
M3 - Article
AN - SCOPUS:85138052505
SN - 2651-4702
VL - 5
SP - 1299
EP - 1310
JO - Journal of Medicinal and Chemical Sciences
JF - Journal of Medicinal and Chemical Sciences
IS - 7
ER -